Welcome to our dedicated page for Siriuspoint SEC filings (Ticker: SSPFF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Siriuspoint's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Siriuspoint's regulatory disclosures and financial reporting.
Donald Smith & Co., Inc. filed a Schedule 13G reporting a passive stake in SiriusPoint Ltd (SPNT). The filer reports 7,402,682 shares beneficially owned, representing 6.34% of the common stock as of the event date 09/30/2025.
The filing lists sole voting power over 7,135,119 shares for Donald Smith & Co., Inc. and 63,073 shares for DSCO Value Fund, L.P., and sole dispositive power over 7,339,609 shares for Donald Smith & Co., Inc. and 63,073 shares for DSCO Value Fund, L.P. The certification states the securities were acquired and are held in the ordinary course and not to change or influence control.
Capital Research Global Investors filed a Schedule 13G reporting beneficial ownership of 6,700,000 shares of SiriusPoint Ltd. (SPNT), representing 5.7% of the class as of the event date September 30, 2025.
The filer reports sole voting power: 6,700,000 and sole dispositive power: 6,700,000, with no shared voting or dispositive power. The percentage is based on 116,759,539 shares believed outstanding. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Wellington Management Group LLP, together with affiliated entities, filed an amended Schedule 13G reporting beneficial ownership in SiriusPoint Ltd. (SPNT).
They reported 4,297,864 shares beneficially owned, representing 3.68% of the common stock, as of the event date 09/30/2025. Wellington reported 0 shares with sole voting or dispositive power, 3,321,795 shares with shared voting power, and 4,297,864 shares with shared dispositive power.
The shares are owned of record by clients of Wellington’s investment adviser affiliates. Wellington stated that no single client is known to have rights to more than five percent of the class and certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
SiriusPoint Ltd. completed the previously announced sale of all membership interests in ArmadaCorp Capital, LLC, the holding company of its supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc.
The Seller received $250 million in cash consideration, subject to deductions including transaction expenses. The transaction closed after satisfaction of customary closing conditions.
SiriusPoint Ltd. (SPNT) reported a stronger quarter. Q3 revenue reached $755.9 million, up from $562.2 million a year ago, driven by higher net premiums earned of $647.7 million. Net income rose to $90.7 million versus $8.7 million, with diluted EPS of $0.73. Underwriting stayed profitable with a combined ratio of 89.1% and underwriting income of $91.4 million. Net investment income was $66.5 million.
The company agreed to sell ArmadaCorp Capital for $250 million, classifying it as held-for-sale and guiding to a pre-tax gain of $220–$230 million, subject to customary closing conditions and regulatory approvals in the fourth quarter of 2025. Operating cash flow improved to $128.8 million for the nine months, while financing cash outflows included $490.8 million of common share repurchases. Shareholders’ equity attributable to SiriusPoint rose to $2,209.9 million, helped by a swing in accumulated other comprehensive income to $52.3 million. Common shares outstanding were 116,814,640 as of October 29, 2025.
SiriusPoint Ltd. (SPNT) filed an 8-K stating it furnished its third-quarter 2025 results press release (Exhibit 99.1), a financial supplement (Exhibit 99.2), and an investor slide presentation (Exhibit 99.3). These materials were provided under Items 2.02 and 7.01 and are not deemed filed under the Exchange Act.
Under Item 8.01, the Audit Committee approved a quarterly cash dividend of $0.50 per share on the company’s 8.00% Resettable Fixed Rate Preference Shares, Series B, payable on November 28, 2025 to shareholders of record on November 13, 2025 (press release in Exhibit 99.4).